menu
    • menu

    Company profile for Evecxia Therapeutics

    NEW Drugs in Dev: 2
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Evecxia Therapeutics is the first company dedicated to realizing the therapeutic potential of serotonin synthesis amplification to enable people with mental illness lead fuller, more meaningful lives. Substantial evidence suggests that appropriate 5-HTP-based Rx drugs could improve the lives of millions of patients with mental disorders not helped by current treatments. Working tirelessly to advance our drug candidates to the ...
    Evecxia Therapeutics is the first company dedicated to realizing the therapeutic potential of serotonin synthesis amplification to enable people with mental illness lead fuller, more meaningful lives. Substantial evidence suggests that appropriate 5-HTP-based Rx drugs could improve the lives of millions of patients with mental disorders not helped by current treatments. Working tirelessly to advance our drug candidates to the market is what drive us.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Evecxia TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2 Davis Drive Research Triangle Park, NC 27709
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://evecxia.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Evecxia Initiates Phase 1B Study For Serotonin Synthesis
    Evecxia Initiates Phase 1B Study For Serotonin Synthesis

    09 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260209575605/en/Evecxia-Doses-First-Patient-in-Phase-1b-Brain-Target-Engagement-Study-of-Serotonin-Synthesis-Amplification-Therapy

    BUSINESSWIRE
    09 Feb 2026
    Share Share
    Evecxia Updates EVX-101 Ph 2 OCD Trial, Raises Financing
    Evecxia Updates EVX-101 Ph 2 OCD Trial, Raises Financing

    22 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250922665286/en/Evecxia-Provides-Financing-Corporate-Updates-Including-Plans-for-an-EVX-101-Proof-of-Concept-Phase-2-Clinical-Study-in-Obsessive-Compulsive-Disorder-OCD-Responding-Inadequately-to-First-line-Therapies

    BUSINESSWIRE
    22 Sep 2025
    Share Share
    Evecxia Therapeutics Appoints C.R. Sincock II To Board Of Directors
    Evecxia Therapeutics Appoints C.R. Sincock II To Board Of Directors

    10 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250410143951/en/Evecxia-Therapeutics-Announces-Appointment-Of-C.R.-Sincock-II-To-The-Board-Of-Directors

    BUSINESSWIRE
    10 Apr 2025
    Share Share
    Evecxia Receives US Patent for EVX-301 in Suicidal Ideation
    Evecxia Receives US Patent for EVX-301 in Suicidal Ideation

    25 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241125283735/en

    BUSINESSWIRE
    25 Nov 2024
    Share Share
    Evecxia Completes PreIND Meeting with FDA for EVX-101 in Depression
    Evecxia Completes PreIND Meeting with FDA for EVX-101 in Depression

    25 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241025211826/en

    BUSINESSWIRE
    25 Oct 2024
    Share Share
    Evecxia Therapeutics ACCESS CHINA Partnering Forum
    Evecxia Therapeutics ACCESS CHINA Partnering Forum

    18 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240918360574/en

    BUSINESSWIRE
    18 Sep 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search